首页 | 本学科首页   官方微博 | 高级检索  
检索        

磺达肝癸钠用于治疗非ST段抬高急性冠脉综合征的临床观察
引用本文:侯小路,王方,白秀萍.磺达肝癸钠用于治疗非ST段抬高急性冠脉综合征的临床观察[J].血栓与止血学,2010,16(5):219-221.
作者姓名:侯小路  王方  白秀萍
作者单位:1. 哈尔滨医科大学附属第四医院心内科,哈尔滨,150001
2. 内蒙古自治区呼和浩特市武警内蒙古总队医院内二科
摘    要:目的观察磺达肝癸钠治疗非ST段抬高急性冠脉综合征的临床疗效及安全性。方法非ST段抬高急性冠脉综合征患者162例,随机分为对照组(80例)和治疗组(82例),两组基础治疗相同。对照组除基础治疗外,给予低相对分子质量肝素5000u,皮下注射,每12h1次,连用7d。治疗组除基础治疗外,给予磺达肝癸钠2.5mg/d皮下注射,连用7d。观察治疗30d内心脏事件发生情况。结果治疗组心绞痛、Q波心肌梗死、死亡、急性冠脉介入治疗、出血并发症例数均较对照组明显减少(P0.05)。结论磺达肝癸钠治疗非ST段抬高急性冠脉综合征安全有效。

关 键 词:磺达肝癸钠  非ST段抬高急性冠脉综合征

Clinical Evaluation of Fondaparinux Na in Treating Non-ST Elevation Acute Coronary Syndrome
HOU Xiao-lu,WANG Fang,BAI Xiu-ping.Clinical Evaluation of Fondaparinux Na in Treating Non-ST Elevation Acute Coronary Syndrome[J].Chinese Journal of Thrombosis and Hemostasis,2010,16(5):219-221.
Authors:HOU Xiao-lu  WANG Fang  BAI Xiu-ping
Institution:HOU Xiao-lu1,WANG Fang2,BAI Xiu-ping1(1.Fourth Hospital of Harbin Medical University,Cardiovascular Department,Harbin,150001,China,2.Inner Mongolian Autonomous Region Huhhot,Armed Police Inner Mongolia Unit Hospital)
Abstract:Objective To observe the clinical value and security of non-ST-segment elevation acute cornary syndrome(NSTE-ACS)by using fondaparinux Na.Methods162 patients with(NSTE-ACS)were selected and randomly divided into control group(80 cases)and treatment group(82 cases).Besides the basic treatment,5 000 u low molecular weight heparin was administrated to the control group subcutaneously every 12 hours for 7 days.The treatment group were given fondaparinux-Na 2.5 mg per day subcutaneously for 7 days.Occurrences of...
Keywords:Fondaparinux-Na  Non-st-segment elevation acute cornary syndrome  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号